Description
BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new cancer immunotherapies.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02024-04-01$38,009,500
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2024-04-01(start date) | $38,009,500 | — | BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new ca… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 819855180)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 033-2024-2025-Q4-515281 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SSF - Science and Research | $38,009,500 | FY2025 |
Other recipients funded under "SSF - Science & Research" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q4-515305 | adMare BioInnovations / BioInnovations adMare|BioInnovations adMare | FY2026 | $5,000,000 | FY2026 |
| 033-2024-2025-Q4-515300 | IC-IMPACTS | FY2026 | $343,137 | FY2026 |
| 033-2024-2025-Q4-515302 | CANADIAN CENTRE FOR AGING & BRAIN HEALTH INNOVATION ADV INC. | FY2026 | $39,179,600 | FY2026 |
| 033-2024-2025-Q4-515290 | Stem Cell Network | FY2026 | $48,485,800 | FY2026 |
| 033-2024-2025-Q4-515295 | Canadian Institute For Advanced Research | FY2025 | $34,480,700 | FY2025 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2024-2025-Q1-515281 · retrieved 2026-11-12.